文献速递角膜与眼表疾病

重复性角膜新生血管化表现为比初始阶段更剧烈的炎症和血管侵入

Repeat Corneal Neovascularization is Characterized by More Aggressive Inflammation and Vessel Invasion Than in the Initial Phase.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究在大鼠角膜缝线诱导新生血管化、拆除缝线30天消退后再缝线,比较第二次与第一次新生血管化反应。结果显示消退后显微镜下仍残留功能极差的持久血管,再刺激后炎症细胞侵入、血管扩张、血管侵入及Vegfa、Il1β、Il6、Ccl2、Ccl3、Cxcl2基因表达均较初始新生血管化加倍,重复新生血管化速度是初始的两倍,局部地塞米松抑制初始新生血管化但未抑制重复新生血管化。

要点

  • 消退30天后角膜透明度恢复,但显微镜下仍残留功能极差的持久血管。
  • 再刺激后炎症细胞侵入、持久血管扩张、血管侵入及多种炎症基因表达均较初始新生血管化加倍。
  • 重复新生血管化速度是初始的两倍,地塞米松抑制初始但未抑制重复新生血管化。

核心结论

  • 初始新生血管化消退后残留的持久血管可快速再激活,促进更剧烈的炎症和重复新生血管化,凸显初始发作后实现并确认血管完全消退的重要性。

研究设计与样本

  • 大鼠角膜缝线放置7天诱导新生血管化,拆除缝线后消退30天,再缝线观察4天。
  • 采用纵向裂隙灯成像、活体共聚焦显微镜和微阵列全局基因表达分析评估炎症和新生血管化反应。
  • 评估局部地塞米松对重复新生血管化的抑制作用。

主要发现

  • 初始强烈新生血管化后,30天消退使角膜透明度恢复,但显微镜下仍残留一群功能极差的持久血管。
  • 再刺激后炎症细胞侵入、持久血管扩张、血管侵入及Vegfa、Il1β、Il6、Ccl2、Ccl3、Cxcl2基因表达均较初始新生血管化加倍。
  • 重复新生血管化发生速度是初始的两倍,伴一氧化氮和活性氧、基质金属蛋白酶及白细胞外渗信号通路激活,抗炎LXR/RXR信号抑制。
  • 地塞米松抑制初始新生血管化,但相似疗程未抑制重复新生血管化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment of corneal neovascularization can lead to vessel regression and recovery of corneal transparency. Here, we examined the response of the cornea to a repeated stimulus after initial vessel regression comparing the second wave of neovascularization with the first. METHODS: Corneal neovascularization was induced by surgical suture placement in the rat cornea for 7 days, followed by suture removal and a 30-day regression period. Corneas were then re-sutured and examined for an additional 4 days. Longitudinal slit-lamp imaging, in vivo confocal microscopy, and microarray analysis of global gene expression was conducted to assess the inflammatory and neovascularization response. Inhibitory effect of topical dexamethasone for repeat neovascularization was assessed. RESULTS: After initial robust neovascularization, 30 days of regression resulted in the recovery of corneal transparency; however, a population of barely functional persistent vessels remained at the microscopic level. Upon re-stimulation, inflammatory cell invasion, persistent vessel dilation, vascular invasion, and gene expression of Vegfa, Il1β, Il6, Ccl2, Ccl3, and Cxcl2 all doubled relative to initial neovascularization. Repeat neovascularization occurred twice as rapidly as initially, with activation of nitric oxide and reactive oxygen species, matrix metalloproteinase, and leukocyte extravasation signaling pathways, and suppression of anti-inflammatory LXR/RXR signaling. While inhibiting initial neovascularization, a similar treatment course of dexamethasone did not suppress repeat neovascularization. CONCLUSIONS: Persistent vessels remaining after the initial resolution of neovascularization can rapidly reactivate to facilitate more aggressive inflammation and repeat neovascularization, highlighting the importance of achieving and confirming complete vessel regression after an initial episode of corneal neovascularization.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Mukwaya A, Mirabelli P, Lennikov A, et al. Repeat Corneal Neovascularization is Characterized by More Aggressive Inflammation and Vessel Invasion Than in the Initial Phase. Invest Ophthalmol Vis Sci. 2019. PMID: 31310656. doi:10.1167/iovs.19-27591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。